Fundraising Fox

Shennon Biotechnologies

San Francisco, US · Founded 2021 · 6 known investors

shennonbio.com ↗

ShennonBio develops immunotherapy technologies using microfluidic engineering, computational biology, and immunology to advance T cell engineering for cancer treatment. The company serves therapeutic development organizations working on cell and gene therapies.

AI & Machine LearningBiotechDeep TechMedical Devicesin /shennon-bio

Founders & leadership

LS
Li Sun, PhDinFounder/CEO
JH
JAMES HARDIMANDirector
LS
LI SUNExecutive Officer, Director

Investors · 6

AV8 VenturesPalo Alto · $500K – $10M
DCVC (Data Collective)Palo Alto · $5M – $25M
Future VenturesLos Altos · $1M – $10M
NextGen Venture PartnersSan Francisco · $500K – $2M
Samos InvestmentsLondon
Foundation CapitalreportedSan Francisco · $250K – $15M

Reported raises · per SEC filings

Form D private placements
▶$7.3MraisedMar 2023 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES HARDIMANDirector
  • LI SUNExecutive Officer, Director
Offering amount
$7.3M
Amount sold
$7.3M
First sale
Dec 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news